Cargando…
Efficacy and safety of Bacillus coagulans LBSC in irritable bowel syndrome: A prospective, interventional, randomized, double-blind, placebo-controlled clinical study [CONSORT Compliant]
GOALS: To evaluate safety and efficacy of Bacillus coagulans LBSC [DSM17654] in irritable bowel syndrome (IBS) through a prospective, interventional, randomized, double-blind, and placebo-controlled, CONSORT compliant clinical trial. BACKGROUND: Bacteriotherapy shows promising impact on alleviating...
Autores principales: | Gupta, Anil Kumar, Maity, Chiranjit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837859/ https://www.ncbi.nlm.nih.gov/pubmed/33545934 http://dx.doi.org/10.1097/MD.0000000000023641 |
Ejemplares similares
-
Probiotic modulation of gut microbiota by Bacillus coagulans MTCC 5856 in healthy subjects: A randomized, double-blind, placebo-control study
por: Majeed, Muhammed, et al.
Publicado: (2023) -
Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study
por: Majeed, Muhammed, et al.
Publicado: (2016) -
Efficacy and safety of Gelidium elegans intake on bowel symptoms in obese adults: A 12-week randomized double-blind placebo-controlled trial
por: Choi, Hyoung Il, et al.
Publicado: (2019) -
Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome: a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study
por: Majeed, Muhammed, et al.
Publicado: (2018) -
The efficacy of a synbiotic containing Bacillus Coagulans in treatment of irritable bowel syndrome: a randomized placebo-controlled trial
por: Rogha, Mehran, et al.
Publicado: (2014)